Clinical Trial Update: Evaluating the Efficacy and Safety of Dolutegravir-Containing Versus Efavirenz-Containing Antiretroviral Therapy Regimens in HIV-1-Infected Pregnant Women and Their Infants [Phase 3]

View source ↗

Summary

Phase 3 trial comparing dolutegravir-containing versus efavirenz-containing ART in HIV-1-infected pregnant women and their infants has completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• dolutegravir-containing antiretroviral therapy (dolutegravir-based regimen)
• efavirenz-containing antiretroviral therapy (efavirenz-based regimen)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2021-11-10